Other OTC Pharmaceuticals - Hong Kong

  • Hong Kong
  • In Hong Kong, the revenue in the Other OTC Pharmaceuticals market is recorded at US$141.50m in 2024.
  • It is projected to experience an annual growth rate of 1.42% (CAGR 2024-2029).
  • When compared to other countries worldwide, the in the United States generates the highest revenue of US$7,171.00m in 2024.
  • Considering the total population, per person revenues amount to US$18.88 in 2024.
  • Hong Kong's Other OTC Pharmaceuticals market is witnessing a surge in demand for traditional Chinese medicines.

Key regions: Europe, Germany, United States, Brazil, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Hong Kong has been experiencing steady growth in recent years. Customer preferences for self-medication and the convenience of over-the-counter products have contributed to this trend. Additionally, local special circumstances and underlying macroeconomic factors have played a role in shaping the market.Customer preferences in Hong Kong have shifted towards self-medication and the use of over-the-counter pharmaceuticals. This can be attributed to several factors. Firstly, consumers in Hong Kong are becoming increasingly health-conscious and are taking a proactive approach to managing their health. They are seeking products that can help them address minor ailments and maintain their well-being without the need for a doctor's prescription. Secondly, the convenience of over-the-counter products is highly appealing to busy urban dwellers in Hong Kong. They prefer the ease of purchasing these products without the hassle of visiting a doctor or waiting for a prescription to be filled.Trends in the Other OTC Pharmaceuticals market in Hong Kong reflect the global market. There is a growing demand for products that address common health concerns such as cold and flu, allergies, digestive issues, and pain relief. Manufacturers are responding to this demand by introducing a wide range of over-the-counter pharmaceuticals that target these specific ailments. Additionally, there is a trend towards natural and herbal remedies, as consumers in Hong Kong are increasingly seeking out products that are perceived as more natural and holistic.Local special circumstances in Hong Kong have also influenced the development of the Other OTC Pharmaceuticals market. Hong Kong has a well-established healthcare system with a high standard of medical care. However, the cost of healthcare services, including doctor consultations and prescription medications, can be relatively high. This has led to a preference for self-medication and over-the-counter products as a more affordable alternative. Additionally, Hong Kong has a large population of expatriates who may be more familiar with over-the-counter products from their home countries and prefer to use these products for minor health issues.Underlying macroeconomic factors have also contributed to the growth of the Other OTC Pharmaceuticals market in Hong Kong. The city has a strong and stable economy, with a high level of disposable income among its residents. This allows consumers to afford over-the-counter products and drives demand in the market. Additionally, Hong Kong's position as a global financial hub and its proximity to mainland China make it an attractive market for international pharmaceutical companies. These companies are able to leverage Hong Kong's well-established distribution networks and reach a wide customer base.In conclusion, the Other OTC Pharmaceuticals market in Hong Kong is experiencing growth due to customer preferences for self-medication and the convenience of over-the-counter products. Local special circumstances, such as the high cost of healthcare and the presence of a large expatriate population, have also influenced the market. Underlying macroeconomic factors, including a strong economy and Hong Kong's global connectivity, have further contributed to the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)